Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Assessing the Probiotic Effects of Pediococcus pentosaceus CACC616 in Weaned Piglets. β
Microorganisms (Microorganisms ) Vol: 11 Issue 12 Pages: Pub: 2023 Nov 30 Epub: 2023 Nov 30 Authors Park S , Song J , Park MA , Jang HJ , Son S , Kim DH , Kim Y , |
|
|
Assessing the Probiotic Effects of Pediococcus pentosaceus CACC616 in Weaned Piglets. β
Microorganisms (Microorganisms ) Vol: 11 Issue 12 Pages: Pub: 2023 Nov 30 Epub: 2023 Nov 30 Authors Park S , Song J , Park MA , Jang HJ , Son S , Kim DH , Kim Y , |
|
|
Pediococcus pentosaceus RC007 and Saccharomyces boulardii RC009 as antibiotic alternatives for gut health in post-weaning pigs. β
Journal of applied microbiology (J Appl Microbiol ) Vol: Issue Pages: Pub: 2024 Nov 5 Epub: 2024 Nov 5 Authors Parada J , Magnoli A , Poloni V , Isgro MC , Cavaglieri LR , Luna MJ , Carranza A , Cavaglieri L , |
|
|
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 6 Pages: 5607-5620 Pub: 2020 Jun 24 Epub: Authors Huang J , Li S , Wang Q , Guan X , Qian L , Li J , Zheng Y , Lin B , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
